🐜
|
Circulating biomarkers for early detection and clinical management of colorectal cancer.
16 auth.
M. Marcuello,
Veronika Vymetálková,
R. Neves,
S. Duran-Sanchon,
H. M. Vedeld,
E. Tham,
G. van Dalum,
G. Flügen,
V. García-Barberán,
R. Fijneman,
...
A. Castells,
P. Vodicka,
G. E. Lind,
N. Stoecklein,
E. Heitzer,
M. Gironella
|
7 |
2019 |
7 🐜
|
🐜
|
Guidelines for the Li–Fraumeni and heritable TP53-related cancer syndromes
46 auth.
Thierry Frébourg,
Svetlana Bajalica Lagercrantz,
Carla Oliveira,
R. Mágenheim,
D. Evans,
N. Hoogerbrugge,
M. Ligtenberg,
M. Kets,
R. Oostenbrink,
R. Sijmons,
G. Evans,
E. Woodward,
M. Tischkowitz,
E. Maher,
R. Ferner,
...
S. Aretz,
I. Spier,
V. Steinke-Lange,
E. Holinski-Feder,
E. Schröck,
Thierry Frébourg,
C. Houdayer,
C. Colas,
P. Wolkenstein,
V. Bours,
E. Legius,
B. Poppe,
K. Claes,
Robin de Putter,
I. Guillermo,
G. Capellá,
J. B. Vidal,
C. Lázaro,
J. Balmaña,
Héctor Salvador Hernández,
Carla Oliveira,
M. Teixeira,
S. Bajalica-Lagercrantz,
E. Tham,
J. Lubiński,
K. Ertmańska,
B. Melegh,
M. Krajc,
A. Blatnik,
S. Peltonen,
M. Hietala
|
7 |
2020 |
7 🐜
|
🐜
|
Identification of nine new susceptibility loci for endometrial cancer
149 auth.
T. O’Mara,
Dylan M Glubb,
Frédéric Amant,
D. Annibali,
K. Ashton,
K. Ashton,
J. Attia,
J. Attia,
P. Auer,
P. Auer,
M. W. Beckmann,
A. Black,
M. Bolla,
H. Brauch,
H. Brauch,
...
H. Brauch,
H. Brenner,
L. Brinton,
D. Buchanan,
B. Burwinkel,
B. Burwinkel,
J. Chang-Claude,
J. Chang-Claude,
S. Chanock,
Chu Chen,
Maxine M Chen,
Timothy H. T. Cheng,
Christine L. Clarke,
M. Clendenning,
Linda S Cook,
Linda S Cook,
F. Couch,
A. Cox,
Marta Crous-Bous,
Marta Crous-Bous,
K. Czene,
F. Day,
J. Dennis,
Jeroen Depreeuw,
J. Doherty,
T. Dörk,
S. Dowdy,
M. Dürst,
A. Ekici,
Peter A. Fasching,
B. Fridley,
C. Friedenreich,
L. Fritschi,
J. Fung,
M. García-Closas,
M. Gaudet,
Graham G. Giles,
Graham G. Giles,
Graham G. Giles,
E. Goode,
Maggie Gorman,
C. Haiman,
Per Hall,
Susan E. Hankison,
Susan E. Hankison,
C. Healey,
A. Hein,
Peter Hillemanns,
Shirley Hodgson,
E. Hoivik,
E. Hoivik,
Elizabeth G. Holliday,
Elizabeth G. Holliday,
J. Hopper,
D. J. Hunter,
Angela Jones,
Camilla Krakstad,
Camilla Krakstad,
V. Kristensen,
V. Kristensen,
D. Lambrechts,
L. Marchand,
Xiaolin Liang,
A. Lindblom,
J. Lissowska,
J. Long,
Lingeng Lu,
A. Magliocco,
Lynn Martin,
M. McEvoy,
A. Meindl,
K. Michailidou,
R. Milne,
R. Milne,
M. Mints,
Grant W. Montgomery,
Grant W. Montgomery,
R. Nassir,
Håkan Olsson,
I. Orlow,
G. Otton,
C. Palles,
J. Perry,
J. Peto,
Loreall Pooler,
J. Prescott,
Tony Proietto,
T. Rebbeck,
H. Risch,
P. Rogers,
M. Rübner,
I. Runnebaum,
C. Sacerdote,
Gloria E. Sarto,
F. Schumacher,
Rodney J. Scott,
Rodney J. Scott,
V. Setiawan,
M. Shah,
Xin Sheng,
X. Shu,
M. Southey,
M. Southey,
Anthony J Swerdlow,
E. Tham,
J. Trovik,
J. Trovik,
Constance Turman,
J. Tyrer,
C. Vachon,
D. Berg,
A. Vanderstichele,
Z. Wang,
P. Webb,
N. Wentzensen,
H. M. Werner,
H. M. Werner,
S. Winham,
A. Wolk,
Lucy Xia,
Y. Xiang,
Hannah P. Yang,
Herbert Yu,
Wei Zheng,
P. Pharoah,
A. Dunning,
P. Kraft,
I. Vivo,
I. Vivo,
Ian Tomlinson,
Ian Tomlinson,
D. Easton,
A. Spurdle,
Deborah J. Thompson
|
7 |
2018 |
7 🐜
|
🐜
|
Integration of whole genome sequencing into a healthcare setting: high diagnostic rates across multiple clinical entities in 3219 rare disease patients
52 auth.
H. Stranneheim,
Kristina Lagerstedt-Robinson,
Måns Magnusson,
M. Kvarnung,
D. Nilsson,
Nicole Lesko,
M. Engvall,
B. Anderlid,
H. Arnell,
C. Johansson,
M. Barbaro,
E. Björck,
Helene Bruhn,
Jesper Eisfeldt,
Christoph Freyer,
...
G. Grigelioniene,
P. Gustavsson,
A. Hammarsjö,
M. Hellström-Pigg,
E. Iwarsson,
Anders Jemt,
Mikael Laaksonen,
S. L. Enoksson,
H. Malmgren,
Karin Naess,
M. Nordenskjöld,
M. Oscarson,
M. Pettersson,
C. Rasi,
A. Rosenbaum,
E. Sahlin,
Eliane Sardh,
T. Stödberg,
B. Tesi,
E. Tham,
H. Thonberg,
V. Töhönen,
U. von Döbeln,
Daphne Vassiliou,
S. Vonlanthen,
A. Wikström,
Josephine Wincent,
O. Winqvist,
A. Wredenberg,
Sofia Ygberg,
R. Zetterström,
P. Marits,
M. Soller,
A. Nordgren,
V. Wirta,
A. Lindstrand,
A. Wedell
|
7 |
2021 |
7 🐜
|
🐜
|
Antimicrobial protein hCAP18/LL‐37 is highly expressed in breast cancer and is a putative growth factor for epithelial cells
9 auth.
J. Heilborn,
M. Nilsson,
Clara I. Chamorro Jimenez,
B. Sandstedt,
N. Borregaard,
E. Tham,
...
O. Sørensen,
G. Weber,
M. Ståhle
|
6 |
2005 |
6 🐜
|
🦁
|
Dominant mutations in KAT6A cause intellectual disability with recognizable syndromic features.
12 auth.
E. Tham,
A. Lindstrand,
A. Santani,
H. Malmgren,
Addie I. Nesbitt,
Holly A. Dubbs,
...
E. Zackai,
M. Parker,
F. Millan,
K. Rosenbaum,
Golder N Wilson,
A. Nordgren
|
6 |
2015 |
6 🦁
|
🦁
|
Clinical testing for mutations in the MEN1 gene in Sweden: a report on 200 unrelated cases.
E. Tham,
U. Grandell,
E. Lindgren,
G. Toss,
B. Skogseid,
M. Nordenskjöld
|
6 |
2007 |
6 🦁
|
🐜
|
From cytogenetics to cytogenomics: whole-genome sequencing as a first-line test comprehensively captures the diverse spectrum of disease-causing genetic variation underlying intellectual disability
30 auth.
A. Lindstrand,
Jesper Eisfeldt,
M. Pettersson,
C. Carvalho,
M. Kvarnung,
G. Grigelioniene,
B. Anderlid,
Olof Bjerin,
P. Gustavsson,
A. Hammarsjö,
P. Georgii‐Hemming,
E. Iwarsson,
Maria Johansson-Soller,
Kristina Lagerstedt-Robinson,
A. Liedén,
...
Måns Magnusson,
Marcel Martin,
H. Malmgren,
M. Nordenskjöld,
A. Norling,
E. Sahlin,
H. Stranneheim,
E. Tham,
Josephine Wincent,
Sofia Ygberg,
A. Wedell,
V. Wirta,
A. Nordgren,
J. Lundin,
D. Nilsson
|
6 |
2019 |
6 🐜
|
🐢
|
Genetic testing and surveillance guidelines in hereditary pheochromocytoma and paraganglioma
10 auth.
A. Muth,
J. Crona,
O. Gimm,
A. Elmgren,
K. Filipsson,
M. S. Askmalm,
...
J. Sandstedt,
M. Tengvar,
E. Tham,
E. Tham
|
6 |
2018 |
6 🐢
|
🐢
|
Genetic testing and surveillance guidelines in hereditary pheochromocytoma and paraganglioma
10 auth.
A. Muth,
J. Crona,
O. Gimm,
A. Elmgren,
K. Filipsson,
M. S. Askmalm,
...
J. Sandstedt,
M. Tengvar,
E. Tham,
E. Tham
|
6 |
2018 |
6 🐢
|